FMII
TVRD

Farmers & Merchants Investments Inc’s Tvardi Therapeutics TVRD Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$59 – 1797
2023
Q3 		$59 Hold
1
– – ﹤0.01% 1751
2023
Q2 		$99 Hold
1
– – ﹤0.01% 1751
2023
Q1 		$172 Hold
1
– – ﹤0.01% 1720
2022
Q4 		$376 Hold
1
– – ﹤0.01% 1658
2022
Q3 		$0 Buy
+1
New +$362 ﹤0.01% 1791

Other funds holding TVRD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Farmers & Merchants Investments Inc's TVRD Position: Q4 2023 in Review

Farmers & Merchants Investments Inc sold out of Tvardi Therapeutics (TVRD) in Q4 2023, closing a stake of 1 share — an estimated $59 sold.

Farmers & Merchants Investments Inc first reported a position in TVRD in Q3 2022 and held it in 5 quarters. The position peaked at $376 in Q4 2022. 109 funds tracked by Wall St. Rank hold TVRD as of Q4 2023.

  • Farmers & Merchants Investments Inc reported no remaining Tvardi Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 1 Tvardi Therapeutics share in Q4 2023, an estimated $59.
  • Farmers & Merchants Investments Inc first reported a position in Tvardi Therapeutics in Q3 2022 and held it in 5 quarters.
  • Farmers & Merchants Investments Inc's Tvardi Therapeutics position peaked at $376 in Q4 2022.
  • 109 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q4 2023, filed 23 Jan 2024.